Ascend Capital Partners

Ascend Capital Partners, founded in 2002 by two Wall Street professionals, is a venture capital firm based in Hong Kong that specializes in providing financial services and lending solutions to real estate sponsors. The firm aims to help companies achieve success by facilitating capital raising and enhancing management standards. Ascend takes an active role in the companies it invests in, participating at both the board and operational levels, and works to establish strategic partnerships. With over USD 100 million in assets generated from successful investments in China and Europe, the firm is dedicated to its partners, as all funds come from their own capital without involvement from third parties. Led by co-founder Monita Mo, Ascend leverages the extensive experience of its partners across various industries and regions, particularly in Asia, to identify and commercialize unique technologies from developed markets. The firm is particularly focused on opportunities in the technology sector, with an emphasis on medical technology and mobility.

Monita Mo

CEO

12 past transactions

Piur Imaging

Series A in 2023
Piur Imaging GmbH, founded in 2014 and headquartered in Vienna, Austria, specializes in developing innovative tomographic ultrasound technology that transforms standard ultrasound systems into advanced 3D imaging devices. Their flagship product, the PIUR tomographic ultrasound (tUS), enhances clinical applications such as endovascular aneurysm repair (EVAR) surveillance, offering superior endoleak detection and classification compared to traditional CT angiography. Additionally, the technology provides high-resolution carotid angiography for better planning of endarterectomy or stent placement and enables rapid 3D vascular mapping of superficial arteries and veins for bypass or arteriovenous fistula planning. Focused on making vascular imaging both affordable and safe, Piur's solutions leverage AI algorithms for efficient diagnostics, particularly in thyroid imaging, allowing for quick and objective analysis of thyroid nodules.

Nanoflex Robotics

Series A in 2023
Nanoflex Robotics is a MedTech startup established in 2021 that focuses on developing a telerobotic platform for remote Mechanical Thrombectomy, aimed at treating ischemic strokes. The company's innovative technology facilitates quicker remote treatments, which can improve patient outcomes and enhance health equity. Additionally, it offers benefits to hospitals by potentially increasing profitability. Nanoflex Robotics has received positive feedback from notable clinical partners, including the Jacobs Institute, Mayo Clinic, and Toronto Health. The firm has also created a proprietary soft robotic system designed to navigate complex vascular anatomy using precise electromagnetic fields, enabling physicians to effectively diagnose and treat vascular diseases such as acute ischemic stroke.

Interventional Systems

Funding Round in 2020
Interventional Systems is a precision medical robotics company focused on enhancing access to micro-invasive medical interventions. Over the past decade, it has integrated advanced technology with medicine to develop innovative, miniature robotics solutions that facilitate precise and efficient image-guided procedures. The company employs parallel kinematics for micro-positioning and patient immobilization, offering advanced positioning systems specifically designed for applications in radiation therapy and neurosurgery. These developments enable healthcare professionals to perform both non-invasive and invasive medical procedures more effectively, ultimately improving patient outcomes in various medical treatments.

Interventional Systems

Series A in 2020
Interventional Systems is a precision medical robotics company focused on enhancing access to micro-invasive medical interventions. Over the past decade, it has integrated advanced technology with medicine to develop innovative, miniature robotics solutions that facilitate precise and efficient image-guided procedures. The company employs parallel kinematics for micro-positioning and patient immobilization, offering advanced positioning systems specifically designed for applications in radiation therapy and neurosurgery. These developments enable healthcare professionals to perform both non-invasive and invasive medical procedures more effectively, ultimately improving patient outcomes in various medical treatments.

Interventional Systems

Funding Round in 2020
Interventional Systems is a precision medical robotics company focused on enhancing access to micro-invasive medical interventions. Over the past decade, it has integrated advanced technology with medicine to develop innovative, miniature robotics solutions that facilitate precise and efficient image-guided procedures. The company employs parallel kinematics for micro-positioning and patient immobilization, offering advanced positioning systems specifically designed for applications in radiation therapy and neurosurgery. These developments enable healthcare professionals to perform both non-invasive and invasive medical procedures more effectively, ultimately improving patient outcomes in various medical treatments.

Neteera

Series A in 2020
Neteera specializes in remote contactless sensing technology that enables continuous and non-invasive monitoring of human vital signs. Utilizing a micro-radar on chip and proprietary algorithms, the company detects microscopic skin motions even through clothing and furniture. This high-frequency sensing technology allows for the monitoring of various physiological parameters, including heart and respiration rates, heart rate variability, inhale-exhale ratio, and tidal volume. By focusing on seamless and safe biometric identification, Neteera provides a cost-effective solution for clients seeking to implement continuous health monitoring without the need for physical contact.

Canatu

Series D in 2018
Canatu is a developer of advanced carbon nanomaterials, specializing in the production of carbon nanotubes (CNTs) for transformative applications in the semiconductor and automotive industries. With over a decade of experience in mass-producing CNTs, the company ensures high-quality, customized solutions to meet specific industry needs. In the semiconductor sector, Canatu's products, including EUV pellicles and debris filters, support the production of advanced microchips. In the automotive industry, the company focuses on film heaters that de-ice LiDAR and camera sensors, facilitating autonomous driving in various weather conditions. Additionally, Canatu is exploring future applications of its CNT technology, particularly in electrochemical sensing. Headquartered in Finland, Canatu also maintains sales offices in the United States, Japan, and Taiwan.

TactoTek

Series B in 2018
TactoTek specializes in injection-molded structural electronics (IMSE®), focusing on the development and licensing of technologies that enable the integration of circuits and components directly into plastic parts. This innovation allows for the transformation of traditional structures into smart, interactive surfaces, catering to sectors such as automotive, aviation, connected home, industrial control, and medical applications. TactoTek's intellectual property portfolio includes over 280 patents and extensive expertise acquired through years of research and development. The company partners with global manufacturers to implement reliable and standardized production methods for curved and conformal electronics, thereby facilitating cost-effective and scalable design solutions that enhance user experiences while promoting sustainability.

TactoTek

Series C in 2017
TactoTek specializes in injection-molded structural electronics (IMSE®), focusing on the development and licensing of technologies that enable the integration of circuits and components directly into plastic parts. This innovation allows for the transformation of traditional structures into smart, interactive surfaces, catering to sectors such as automotive, aviation, connected home, industrial control, and medical applications. TactoTek's intellectual property portfolio includes over 280 patents and extensive expertise acquired through years of research and development. The company partners with global manufacturers to implement reliable and standardized production methods for curved and conformal electronics, thereby facilitating cost-effective and scalable design solutions that enhance user experiences while promoting sustainability.

Canatu

Venture Round in 2017
Canatu is a developer of advanced carbon nanomaterials, specializing in the production of carbon nanotubes (CNTs) for transformative applications in the semiconductor and automotive industries. With over a decade of experience in mass-producing CNTs, the company ensures high-quality, customized solutions to meet specific industry needs. In the semiconductor sector, Canatu's products, including EUV pellicles and debris filters, support the production of advanced microchips. In the automotive industry, the company focuses on film heaters that de-ice LiDAR and camera sensors, facilitating autonomous driving in various weather conditions. Additionally, Canatu is exploring future applications of its CNT technology, particularly in electrochemical sensing. Headquartered in Finland, Canatu also maintains sales offices in the United States, Japan, and Taiwan.

Aiforia

Series A in 2017
Aiforia Technologies, founded in 2013 as a spin-off from the Finnish Institute for Molecular Medicine at the University of Helsinki, specializes in cloud-based microscopy and pathology. The company offers the Aiforia® Platform, which combines deep learning artificial intelligence with high-performance cloud computing to enhance image-based diagnostics. Aiforia's solutions aim to increase efficiency and scalability in medical image analysis, supporting pathologists and scientists in both preclinical and clinical settings. By providing highly accurate and consistent data, Aiforia facilitates new discoveries and clinical decision-making across various disciplines, including oncology and neuroscience. The platform's image-agnostic capabilities allow it to extend its applications beyond traditional boundaries, positioning Aiforia as a leader in advancing medical imaging technology.

Grundium

Venture Round in 2017
Grundium specializes in the development of portable digital microscope scanners aimed at enhancing the field of digital pathology. By utilizing cutting-edge mobile technology, the company enables high-quality professional diagnoses applicable to humans, animals, plants, and more. Its innovative products facilitate live telepathology consultations between surgeons and pathologists, allowing for the scanning and digitization of high-resolution images directly from operating rooms and research centers. This approach not only improves the accessibility and quality of diagnostic pathology but also significantly reduces time and costs associated with traditional methods.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.